In every state across America, Medicaid programs are under serious budgetary pressure. The need to contain costs has led to various forms of restriction in the coverage for drug therapy, including ...

Retrospective analysis of medical and pharmacy claims for patients diagnosed with schizophrenia or bipolar disorder in 24 state Medicaid programs. Applying formulary restrictions to atypical ...

Objective: To review clinical trials and reports describing the efficacy and safety of atypical antipsychotics (olanzapine, ziprasidone, quetiapine, aripiprazole) in the treatment of autistic or other ...

About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify “might be right for them.” Few appeared to be ...

Atypical antipsychotic medications, developed to treat schizophrenia and bipolar disorder, are frequently prescribed for many off-label uses. A new study finds that medical evidence suggests the drugs ...

The introduction of atypical antipsychotics represents an advance in the treatment of schizophrenia because they are generally better tolerated than conventional antipsychotics and have been ...

Do you still use atypical antipsychotics as a first-line medical treatment for agitated patients with Alzheimer's disease? Has the role of atypical antipsychotics for Alzheimer's patients changed ...

A review of previous studies suggests that even though atypical antipsychotic medications are commonly used for off-label conditions such as behavioral symptoms of dementia, anxiety, and ...

Antipsychotic drugs are frequently prescribed as a treatment for the behavioral symptoms of dementia. Compared with use of atypical antipsychotics, the use of typical antipsychotics is commonly ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify iwaters@healio.com if there are concerns ...

Schneider et al. (Oct. 12 issue) 1 conclude that the adverse effects of atypical antipsychotic drugs for the treatment of psychosis, aggression, and agitation in patients with Alzheimer's disease ...

Alzheimer’s Death Rate Steadily Increasing; FDA Offers New Guidance Atypical antipsychotics are known to improve many of the symptoms experienced by elderly patients who exhibit neuropsychiatric ...